Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 1—January 2005

Demand for Prophylaxis after Bioterrorism-Related Anthrax Cases, 2001

Edward A. Belongia*Comments to Author , Burney Kieke*, Ruth Lynfield†, Jeffrey P. Davis‡, and Richard E. Besser§
Author affiliations: *Marshfield Clinic Research Foundation, Marshfield, Wisconsin, USA; †Minnesota Department of Health, Minneapolis, Minnesota, USA; ‡Wisconsin Division of Public Health, Madison, Wisconsin, USA; §Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article


Characteristics of Minnesota and Wisconsin clinicians who received requests for antimicrobial agents to prevent anthrax during the last quarter of 2001

Received requests (%) p value
Prescriber type
Physician 52/157 (33) <0.001
Nonphysician 6/52 (12)
Practice location
Metropolitan area 22/82 (27) 0.82
Nonmetropolitan area 36/128 (28)
Minnesota 29/105 (28) 1.0
Wisconsin 29/105 (28)
Physician specialty*
Family practice 26/62 (41) 0.61
Internal medicine 14/42 (30)
Pediatrics 8/28 (28)
Emergency medicine 2/5 (33)

*Nine physicians who listed 2 specialties and 2 who listed “other” as a specialty were excluded from the frequency distribution for physician specialty.

Main Article

Page created: April 14, 2011
Page updated: April 14, 2011
Page reviewed: April 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.